ENDRA Life Sciences (NDRA) Other Non Operating Income (2016 - 2021)
Historic Other Non Operating Income for ENDRA Life Sciences (NDRA) over the last 6 years, with Q4 2021 value amounting to -$617200.0.
- ENDRA Life Sciences' Other Non Operating Income fell 1733540.91% to -$617200.0 in Q4 2021 from the same period last year, while for Dec 2021 it was -$315021.0, marking a year-over-year decrease of 366277.99%. This contributed to the annual value of -$690800.0 for FY2024, which is 25001.57% down from last year.
- ENDRA Life Sciences' Other Non Operating Income amounted to -$617200.0 in Q4 2021, which was down 1733540.91% from -$7507.0 recorded in Q3 2021.
- ENDRA Life Sciences' Other Non Operating Income's 5-year high stood at $308600.0 during Q1 2021, with a 5-year trough of -$617200.0 in Q4 2021.
- Its 5-year average for Other Non Operating Income is -$44415.0, with a median of -$2621.0 in 2020.
- Over the last 5 years, ENDRA Life Sciences' Other Non Operating Income had its largest YoY gain of 456374.49% in 2021, and its largest YoY loss of 1733540.91% in 2021.
- Over the past 5 years, ENDRA Life Sciences' Other Non Operating Income (Quarter) stood at $1931.0 in 2017, then crashed by 979.85% to -$16990.0 in 2018, then plummeted by 203.56% to -$51575.0 in 2019, then surged by 106.94% to $3581.0 in 2020, then crashed by 17335.41% to -$617200.0 in 2021.
- Its last three reported values are -$617200.0 in Q4 2021, -$7507.0 for Q3 2021, and $1086.0 during Q2 2021.